Litcius/Paper detail

Loganic acid protects against ulcerative colitis by inhibiting TLR4/NF-κB mediated inflammation and activating the SIRT1/Nrf2 anti-oxidant responses in-vitro and in-vivo

Arun N. Prakash, Neethu Prasad, Eswara Rao Puppala, Samir Ranjan Panda, Siddhi Jain, V. Ravichandiran, Meenakshi Singh, V.G.M. Naidu

2023International Immunopharmacology47 citationsDOI

Topics & Concepts

Oxidative stressChemistryUlcerative colitisInflammationTLR4ColitisNF-κBIn vivoPharmacologyGlutathioneIκBαTumor necrosis factor alphaBiochemistryImmunologySignal transductionBiologyMedicineInternal medicineEnzymeDiseaseBiotechnologyPharmacological Effects of Natural CompoundsGenomics, phytochemicals, and oxidative stressNatural product bioactivities and synthesis
Loganic acid protects against ulcerative colitis by inhibiting TLR4/NF-κB mediated inflammation and activating the SIRT1/Nrf2 anti-oxidant responses in-vitro and in-vivo | Litcius